BioCentury
ARTICLE | Company News

FDA approves OraSure benzodiazepine diagnostic

April 19, 2002 7:00 AM UTC

The FDA granted 510(k) marketing clearance for an oral benzodiazepine diagnostic from OSUR. The test will be available as part of the company's Intercept laboratory-based drug testing service, which s...